Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era
Authors:
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 19 (4) , 591-604
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infectionHepatology, 2013
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalenceHepatology, 2013
- Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective StudyThe Journal of Infectious Diseases, 2012
- Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis TrialGastroenterology, 2009
- Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infectionHepatology, 2008
- Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *Hepatology, 2005
- Impact of hepatitis C on health related quality of lifeHepatology, 2005
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGastroenterology, 1997
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989